Structure of Domatinostat
CAS No.: 910462-43-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Domatinostat is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. Also displays inhibitory activity against Lysine specific demethylase 1 (LSD1).
Synonyms: 4SC-202 free base; 4SC-202
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 910462-43-0 |
Formula : | C23H21N5O3S |
M.W : | 447.51 |
SMILES Code : | O=C(NC1=CC=CC=C1N)/C=C/C2=CN(S(=O)(C3=CC=C(C4=CN(C)N=C4)C=C3)=O)C=C2 |
Synonyms : |
4SC-202 free base; 4SC-202
|
MDL No. : | MFCD28155264 |
InChI Key : | PRXXYMVLYKJITB-IZZDOVSWSA-N |
Pubchem ID : | 15985904 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
PANC1 and ASPC1 cells | 0.5 μM and 1 μM | 16 hours | To evaluate the effect of Domatinostat on CD133 protein expression, results showed Domatinostat reduced CD133 expression. | PMC9004159 |
HFOB 1.19 | 1 μM | 24 h | Inhibits cell growth and proliferation, increases histone H3 acetylation levels | PMC8394112 |
SJSA-1 | 1 μM | 24 h | Inhibits cell growth and proliferation, increases histone H3 acetylation levels | PMC8394112 |
Primary skin fibroblasts | 2.5 μM | 24 hours | No G2M arrest or apoptosis observed | PMC7987731 |
UM-MCC34 cells | 2.5 μM | 24 hours | Induced G2M cell cycle arrest and apoptosis, upregulated APM component gene expression | PMC7987731 |
MKL-2 cells | 2.5 μM | 24 hours | Induced G2M cell cycle arrest and apoptosis, upregulated APM component gene expression | PMC7987731 |
MKL-1 cells | 2.5 μM | 24 hours | Induced G2M cell cycle arrest and apoptosis, upregulated APM component gene expression | PMC7987731 |
WaGa cells | 2.5 μM | 24 hours | Induced G2M cell cycle arrest and apoptosis, upregulated APM component gene expression | PMC7987731 |
Panc1 cells | 1 μM | 24 or 72 hours | 4SC-202 significantly inhibited the proliferation of Panc1 cells and induced p21 expression. | PMC5499659 |
BxPC3 cells | 1 μM | 24 or 72 hours | 4SC-202 significantly inhibited the proliferation of BxPC3 cells and induced p21 expression. | PMC5499659 |
L3.6 cells | 1 μM | 24 or 72 hours | 4SC-202 significantly inhibited the proliferation of L3.6 cells and induced p21 expression. | PMC5499659 |
IMR90 human normal lung fibroblasts | 500 nM | 3 days | Domatinostat did not affect cell viability | PMC10341571 |
SKOV3 ovarian serous cancer cells | 125-250 nM | 3 days | Domatinostat reduced FOXM1 mRNA and protein expression levels in a concentration-dependent manner | PMC10341571 |
TOV21G ovarian clear cell cancer cells | 125-250 nM | 3 days | Domatinostat reduced FOXM1 mRNA and protein expression levels in a concentration-dependent manner | PMC10341571 |
Human lung fibroblasts (IMR90) | 500 nM | 3 days | To evaluate the effect of Domatinostat on normal cells, results showed no significant impact on the growth of IMR90 cells at 500 nM. | PMC9332065 |
Glioma stem cells (TGS01) | 500 nM | 3 days | To evaluate the inhibitory effect of Domatinostat on the growth of glioma stem cells, results showed that Domatinostat significantly inhibited the growth of TGS01 cells at 500 nM. | PMC9332065 |
Glioma stem cells (GS-Y03) | 500 nM | 3 days | To evaluate the inhibitory effect of Domatinostat on the growth of glioma stem cells, results showed that Domatinostat significantly inhibited the growth of GS-Y03 cells at 500 nM. | PMC9332065 |
Glioma stem cells (GS-Y01) | 500 nM | 3 days | To evaluate the inhibitory effect of Domatinostat on the growth of glioma stem cells, results showed that Domatinostat significantly inhibited the growth of GS-Y01 cells at 500 nM. | PMC9332065 |
MDA-MB-231 cells | 100 nM to 10 µM | 6 days | To evaluate the cytotoxic and cytostatic effects of 4SC-202 on MDA-MB-231 cells, showing significant reduction in colony formation at concentrations of 100 nM to 10 µM | PMC8996906 |
MCF10A cells | 1 to 10 µM | 7 days | To evaluate the toxicity of 4SC-202 on normal breast epithelial cells, showing no cytotoxicity to MCF10A cells at concentrations ranging from 1 to 10 µM | PMC8996906 |
PANC1 and ASPC1 spheroid cultures | 0.5 μM | 7 days | To evaluate the effect of Domatinostat on pancreatic cancer stem cell spheroid formation, results showed Domatinostat reduced spheroid numbers. | PMC9004159 |
4T1 cells | 0.1 nM to 10 µM | 72 hours | To evaluate the cytotoxic effects of 4SC-202 on 4T1 cells, showing significant reduction in cell viability at concentrations ranging from 0.1 µM to 10 µM | PMC8996906 |
PANC28 | 0.5 μM | 96 hours | To evaluate the anti-tumor effect of Domatinostat in combination with chemotherapeutic agents, showing synergistic anti-proliferative and pro-apoptotic effects. | PMC8892808 |
ASPC1 | 0.5 μM | 96 hours | To evaluate the anti-tumor effect of Domatinostat in combination with chemotherapeutic agents, showing synergistic anti-proliferative and pro-apoptotic effects. | PMC8892808 |
PANC1 | 0.5 μM | 96 hours | To evaluate the anti-tumor effect of Domatinostat in combination with chemotherapeutic agents, showing synergistic anti-proliferative and pro-apoptotic effects. | PMC8892808 |
PANC1 and ASPC1 spheroids | 0.5 μM and 1 μM | To evaluate the effect of Domatinostat on spheroid viability, results showed Domatinostat reduced spheroid viability. | PMC9004159 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
NMRI foxn1nu/nu mice | Subcutaneous xenograft model of pancreatic cancer with L3.6 cells | Oral gavage | 120 mg/kg | Twice daily for 4 days | 4SC-202 significantly inhibited tumor growth. | PMC5499659 |
Athymic mice | PANC28 and PANC1 xenograft models | Oral | 20 mg/kg | 5 days/week, for 3 weeks | To evaluate the anti-tumor effect of Domatinostat in combination with chemotherapeutic agents, showing significant reduction in tumor volume and synergistic anti-tumor effects. | PMC8892808 |
Athymic mice | Pancreatic cancer xenograft model | Oral | 20 mg/kg | 5 days/week for two weeks | To evaluate the effect of Domatinostat alone or in combination with chemotherapy on pancreatic cancer xenografts, results showed Domatinostat enhanced chemotherapy efficacy. | PMC9004159 |
BALB/c mice | CT26 tumor model | Oral | 20 mg/kg twice daily or 60 mg/kg once daily | 12-14 days (CT26) or up to 24 days (C38) | Domatinostat reduced tumor volume in immunocompetent mice, increased the number of CTLs in the tumor core, improved the CTL/Treg ratio, and enhanced antitumor immune responses. | PMC6839078 |
BALB/c mice | 4T1 breast cancer model | Intraperitoneal injection | 50 mg/kg | Three times per week for 21 days | To evaluate the effects of 4SC-202 on tumor growth and metastasis, showing that 50 mg/kg dose significantly reduced tumor burden and lung metastasis | PMC8996906 |
Athymic nude mice | Human osteosarcoma xenograft model | Intraperitoneal injection | 50 mg/kg/day | Once daily for 16 days | Reduces tumor growth, tumor mass significantly decreased by 70.56% | PMC8394112 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01344707 | Advanced Hematologic Malignanc... More >>ies Less << | PHASE1 | COMPLETED | 2025-03-15 | Universi?tsklinikum K?ln, K?ln... More >>, Germany|Robert-Bosch-Krankenhaus, Stuttgart, Germany|Universit?tsklinikum Würzburg, Würzburg, Germany Less << |
Tags: Domatinostat | 4SC-202 | HDAC | Apoptosis | Histone deacetylases | HDAC inhibitor | class I HDAC | LSD1 inhibitor | epigenetic modulation | HDAC1 inhibitor | HDAC2 inhibitor | HDAC3 inhibitor | Lysine-specific demethylase 1 | 910462-43-0
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL